# 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease

> **NCT01316900** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 846 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK573719/GW642444 125/25
- **DRUG:** GSK573719/GW642444 62.5/25
- **DRUG:** GW642444
- **DRUG:** tiotropium bromide

## Key facts

- **NCT ID:** NCT01316900
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-01
- **Primary completion:** 2012-04-01
- **Final completion:** 2012-04-24
- **Target enrollment:** 846 (ACTUAL)
- **Last updated:** 2018-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01316900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01316900, "24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01316900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*